BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 28034845)

  • 1. Thirty-Day Readmissions After Transcatheter Aortic Valve Replacement in the United States: Insights From the Nationwide Readmissions Database.
    Kolte D; Khera S; Sardar MR; Gheewala N; Gupta T; Chatterjee S; Goldsweig A; Aronow WS; Fonarow GC; Bhatt DL; Greenbaum AB; Gordon PC; Sharaf B; Abbott JD
    Circ Cardiovasc Interv; 2017 Jan; 10(1):. PubMed ID: 28034845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, Causes, and Predictors of Early (≤30 Days) and Late Unplanned Hospital Readmissions After Transcatheter Aortic Valve Replacement.
    Nombela-Franco L; del Trigo M; Morrison-Polo G; Veiga G; Jimenez-Quevedo P; Abdul-Jawad Altisent O; Campelo-Parada F; Biagioni C; Puri R; DeLarochellière R; Dumont E; Doyle D; Paradis JM; Quirós A; Almeria C; Gonzalo N; Nuñez-Gil I; Salinas P; Mohammadi S; Escaned J; Fernández-Ortiz A; Macaya C; Rodés-Cabau J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1748-57. PubMed ID: 26476610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and readmissions after transcatheter and surgical aortic valve replacement in patients with cirrhosis: A propensity matched analysis.
    Dhoble A; Bhise V; Nevah MI; Balan P; Nguyen TC; Estrera AL; Smalling RW
    Catheter Cardiovasc Interv; 2018 Jan; 91(1):90-96. PubMed ID: 28846185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Hospital Volume and 30-Day Readmissions Following Transcatheter Aortic Valve Replacement.
    Khera S; Kolte D; Gupta T; Goldsweig A; Velagapudi P; Kalra A; Tang GHL; Aronow WS; Fonarow GC; Bhatt DL; Aronow HD; Kleiman NS; Reardon M; Gordon PC; Sharaf B; Abbott JD
    JAMA Cardiol; 2017 Jul; 2(7):732-741. PubMed ID: 28494061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Length of Stay and Discharge Disposition After Transcatheter Versus Surgical Aortic Valve Replacement in the United States.
    Arora S; Strassle PD; Kolte D; Ramm CJ; Falk K; Jack G; Caranasos TG; Cavender MA; Rossi JS; Vavalle JP
    Circ Cardiovasc Interv; 2018 Sep; 11(9):e006929. PubMed ID: 30354596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early readmissions after transcatheter and surgical aortic valve replacement.
    Vejpongsa P; Bhise V; Charitakis K; Vernon Anderson H; Balan P; Nguyen TC; Estrera AL; Smalling RW; Dhoble A
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):662-670. PubMed ID: 28251807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends, Predictors, and Outcomes of 30-Day Readmission With Heart Failure After Transcatheter Aortic Valve Replacement: Insights From the US Nationwide Readmission Database.
    Zahid S; Din MTU; Khan MZ; Rai D; Ullah W; Sanchez-Nadales A; Elkhapery A; Khan MU; Goldsweig AM; Singla A; Fonarrow G; Balla S
    J Am Heart Assoc; 2022 Aug; 11(16):e024890. PubMed ID: 35929464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants and Impact of Heart Failure Readmission Following Transcatheter Aortic Valve Replacement.
    Auffret V; Bakhti A; Leurent G; Bedossa M; Tomasi J; Belhaj Soulami R; Verhoye JP; Donal E; Galli E; Loirat A; Sharobeem S; Sost G; Le Guellec M; Boulmier D; Le Breton H
    Circ Cardiovasc Interv; 2020 Jul; 13(7):e008959. PubMed ID: 32600108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital outcomes of transcatheter versus surgical aortic valve replacement in female in the United States.
    Ando T; Akintoye E; Telila T; Briasoulis A; Takagi H; Schreiber T; Afonso L; Grines CL
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):813-819. PubMed ID: 28990736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of mitral stenosis on outcomes of aortic valve stenosis patient undergoing surgical aortic valve replacement or transcatheter aortic valve replacement.
    Al-Khadra Y; Darmoch F; Baibars M; Kaki A; Fanari Z; Alraies MC
    J Interv Cardiol; 2018 Oct; 31(5):655-660. PubMed ID: 29774601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-hospital outcomes of transcatheter versus surgical aortic valve replacement in end stage renal disease.
    Alkhalil A; Golbari S; Song D; Lamba H; Fares A; Alaiti A; Deo S; Attizzani GF; Ibrahim H; Ruiz CE
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):757-765. PubMed ID: 29171682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Causes and Associated Costs of 30-Day Readmission of Transcatheter Implantation Versus Surgical Aortic Valve Replacement in the United States (A National Readmission Database Study).
    Tripathi A; Flaherty MP; Abbott JD; Fonarow GC; Khan AR; Saraswat A; Chahil H; Kolte D; Elmariah S; Hirsch GA; Mathew V; Kirtane AJ; Bhatt DL
    Am J Cardiol; 2018 Aug; 122(3):431-439. PubMed ID: 29960664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Costs and Risk Factors of 30-Day Readmissions for Transcatheter Aortic Valve Implantation.
    Arora S; Hendrickson MJ; Strassle PD; Qamar A; Pandey A; Kolte D; Sitammagari K; Cavender MA; Fonarow GC; Bhatt DL; Vavalle JP
    Am J Cardiol; 2020 Dec; 137():89-96. PubMed ID: 32991853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Readmission After Surgical Aortic Valve Replacement in the United States.
    Khoury H; Ragalie W; Sanaiha Y; Boutros H; Rudasill S; Shemin RJ; Benharash P
    Ann Thorac Surg; 2020 Sep; 110(3):849-855. PubMed ID: 31981500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental cost and length of stay associated with postprocedure delirium in transcatheter and surgical aortic valve replacement patients in the United States.
    Potter BJ; Thompson C; Green P; Clancy S
    Catheter Cardiovasc Interv; 2019 May; 93(6):1132-1136. PubMed ID: 30549428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National trends and 30-day readmission rates for next-day-discharge transcatheter aortic valve replacement: An analysis from the Nationwide Readmissions Database, 2012-2016.
    Yerasi C; Tripathi B; Wang Y; Forrestal BJ; Case BC; Khan JM; Torguson R; Ben-Dor I; Satler LF; Garcia-Garcia HM; Weintraub WS; Rogers T; Waksman R
    Am Heart J; 2021 Jan; 231():25-31. PubMed ID: 33091365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, Predictors, and Outcomes of Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Analysis From the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry.
    Fadahunsi OO; Olowoyeye A; Ukaigwe A; Li Z; Vora AN; Vemulapalli S; Elgin E; Donato A
    JACC Cardiovasc Interv; 2016 Nov; 9(21):2189-2199. PubMed ID: 27832844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital Variation in 30-Day Readmissions Following Transcatheter Aortic Valve Replacement.
    Kolte D; Kennedy K; Wasfy JH; Jena AB; Elmariah S
    J Am Heart Assoc; 2021 May; 10(10):e021350. PubMed ID: 33938233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and predictors of readmissions to non-index hospitals after transcatheter aortic valve replacement and the impact on in-hospital outcomes: From the nationwide readmission database.
    Ando T; Adegbala O; Villablanca P; Akintoye E; Ashraf S; Shokr M; Siddiqui F; Takagi H; Grines CL; Afonso L; Briasoulis A
    Int J Cardiol; 2019 Oct; 292():50-55. PubMed ID: 31053244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Readmission rates after transcatheter aortic valve replacement in high- and extreme-risk patients with severe aortic stenosis.
    Forcillo J; Condado JF; Binongo JN; Lasanajak Y; Caughron H; Babaliaros V; Devireddy C; Leshnower B; Guyton RA; Block PC; Simone A; Keegan P; Khairy P; Thourani VH
    J Thorac Cardiovasc Surg; 2017 Aug; 154(2):445-452. PubMed ID: 28532575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.